SCHEMBL92616

SCHEMBL92616

CC1CCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13663738 1.00
SCHEMBL17113664 1.00
Ammonia Solution, Strong SCHEMBL12500116 0.96
Hydrochloric Acid SCHEMBL2713997 0.96
Hydrochloric Acid SCHEMBL21590180 0.93
SCHEMBL15283001 0.83
Formamide SCHEMBL14779600 0.83
SCHEMBL88667 0.79
SCHEMBL254419 0.79
SCHEMBL292798 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113278201-B Preparation process of multifunctional silane coupling agent 安徽沸点新材料有限公司 2023-03-07 CN claimed
CN-113278201-A Preparation process of multifunctional silane coupling agent 安徽沸点新材料有限公司 2021-08-20 CN claimed
CN-103889986-B Novel heterocyclic derivatives and their use C&C新药研究所 2017-07-21 CN claimed
EP-2501236-B1 N-[2-fluoro-3-(4-amino-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-phenyl]-4-benzenesulfonamide derivatives as Raf protein kinase modulators for the treatment of cancer PLEXXIKON INC (US) 2017-03-29 EP claimed
US-8673928-B2 Compounds and methods for kinase modulation, and indications therefor PLEXXIKON INC. (US) 2014-03-18 US claimed
CN-102585109-B Styrene-acrylic emulsion and preparation method thereof GUANGZHOU STARTEC SCIENCE & TECHNOLOGY CO LTD 2013-12-18 CN claimed
EP-2501236-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR Plexxikon, Inc. (US) 2012-09-26 EP claimed
CN-102585109-A Styrene-acrylic emulsion and preparation method thereof GUANGZHOU STAR TECHNOLOGY CO LTD 2012-07-18 CN claimed
US-20110152258-A1 Compounds and Methods for Kinase Modulation, and Indications Therefor PLEXXIKON INC. 2011-06-23 US claimed
WO-2011063159-A1 COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR PLEXXIKON, INC. (US) 2011-05-26 WO claimed
US-20100152237-A1 BIS-PYRINDINO CONTAINING COMPOUNDS FOR THE USE IN THE TREATMENT OF CNS PATHOLOGIES UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2010-06-17 US claimed
US-20080287490-A1 Bis-pyridino containing compounds for the use in the treatment of CNS pathologies UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2008-11-20 US claimed
US-20050261334-A1 Bis-pyridino containing compounds for the use in the treatment of CNS pathologies UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2005-11-24 US claimed
WO-2005066129-A2 BIS-PYRIDINO CONTAINING COMPOUNDS FOR USE IN THE TREATMENT OF CNS PATHOLOGIES UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2005-07-21 WO claimed
US-12612387-B2 RAS inhibitors and methods of using the same JAZZ PHARMACEUTICALS IRELAND LIMITED (IE) 2026-04-28 US disclosed
US-20260042748-A1 AZETIDINE COMPOUNDS FOR TREATMENT OF HSV ASSEMBLY BIOSCIENCES INC (US) 2026-02-12 US disclosed
US-20250250232-A1 AZETIDINE DERIVATIVES AND USE THEREOF AS DIPEPTIDYL PEPTIDASE 1 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2025-08-07 US disclosed
EP-0536035-A1 1,8-Benzonaphthyridine derivatives and antimicrobial compositions LABORATOIRE ROGER BELLON (FR) 1993-04-07 EP disclosed
EP-0387567-A2 Amphoteric polyelectrolyte, method for production thereof, and organic sludge dehydrater NIPPON SHOKUBAI CO., LTD. (JP) 1990-09-19 EP disclosed
US-4735959-A HYPOGLYCEMIC AGENTS DR. KARL THOMAE GMBH (DE) 1988-04-05 US disclosed